Neprinol.org | An educational site about the systemic enzyme formula Neprinol

Fibrin Defense

Fibrin is a protein formed in the human body responsible for scar tissue and thrombus formation. Neprinol contains a blend of fibrinolytic (fibrin degrading) enzymes that specifically address fibrin levels in the body. When healthy, our bodies will normally secrete sufficient levels of plasmin, our own natural blood thinner, which is responsible for maintaining normal blood solvency by removing unnecessary accumulated protein. Read More...

Neprinol Suggested Use

Directions: Take 1 to 4 capsules with 8 oz of water between meals or as directed by your healthcare practitioner. For therapeutic applications, take 3 or 4 capsules three times daily. Read More...

Neprinol FAQ’s

What is Neprinol?Neprinol is a proprietary combination of Nattokinase, Serrapeptase, Rutin, Amla and other proteolytic enzymes that are specially formulated to assist your body's defense of the damaging effects of fibrin. Neprinol has been used to strengthen the immune and circulatory systems, maintain a healthy inflammatory response and to support the body's natural recovery process. Read More...

Neprinol Side Effects

No serious or adverse side effects or hospitalizations have been reported from taking systemic enzymes such as Neprinol. Clinical studies have shown that even extremely large doses of these natural enzymes are not toxic. Enzymes may detoxify the body, but this is not considered a side effect. Dissolving fibrin may release, Read More...

Is Neprinol Enteric Coated?

Certain websites and manufacturers have recently been marketing that enzymes require a pH resistant coating (known as an enteric coating) to be effective systemically. Many enzymes have been used for decades for their systemic properties, yet the enteric coating gimmick has only been around for a few years. A common misconception with enzymes is that they “die” if they enter an environment which is not within their optimal range of pH and temperature. Read More...

Neprinol Osteoarthritis Study

Study Subject: 45 y/o Male construction worker, recently diagnosed with Osteoarthritis. Patients’ blood shows significant protein polymerization, raised platelets, raised poikilocytes, raised fibrin and raised WBCs.

Neprinol Rheumatoid Arthritis Study

Study Subject: 67 y/o Female retired administrator, diagnosed with Rheumatoid Arthritis 5 years ago. Patient has been using NSAID’s for pain since diagnosis 5 years ago. Patient’s blood shows significant protein (oxidative stress) polymerization and fibrin.

Neprinol Diabetes Study

Study Subject: 26 y/o old Female graduate student. Recently diagnosed with Hyperinsulinemia (Pre-diabetes). Subject is also overweight and complains of chronic fatigue. Patient has been following an appropriate diet and has been engaged in regular exercise for the past 6 months – but is frustrated with lack of results.

Neprinol LDL Cholesterol Study

Study Subject: 44 y/o Male company executive, just diagnosed with Hyperlipidemia (High Cholesterol). Does not want to take cholesterol-lowering drugs. No supplements are currently being taken.

Canadian Physician Reference Manual